Loading…
COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles
Objective: To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Methods: Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outco...
Saved in:
Published in: | Cerebrovascular Diseases 2021-12, Vol.50 (6), p.707-714 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Request full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c550t-b783ec4feef22beda820bacce4ba62cf0bfee3756c5d13f9d5f1b21dfb7343a73 |
---|---|
cites | cdi_FETCH-LOGICAL-c550t-b783ec4feef22beda820bacce4ba62cf0bfee3756c5d13f9d5f1b21dfb7343a73 |
container_end_page | 714 |
container_issue | 6 |
container_start_page | 707 |
container_title | Cerebrovascular Diseases |
container_volume | 50 |
creator | Padrick, M. Maximillian Sangha, Navdeep Paletz, Laurie Mirocha, James Figueroa, Sonia Manoukian, Vicki Schlick, Konrad Lyden, Patrick D. Liebeskind, David S. Chatfield, Fiona K. Tarpley, Jason W. Burgos, Adrian Tenser, Matthew Gaffney, Denise Pech, Marco A. Nazareth, Edward Jackson, Robert Kauffman, Helaine Arnold, Lisa Cox, Jennifer Joyce, Treasure Nakamura, Catrice Fitzgerald, Darcie Ogami, Kyle Steiner, Nili Wolber, Nicole Robertson, Betty Izzo, Rachel Gorski, Stefanie Manuel, Heather Valdez, Krystal Reyes, Liliana Sharma, Latisha K. Song, Shlee S. |
description | Objective: To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Methods: Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. Results: There was a 17.3% decrease in stroke code activations across LAC in 2020 compared to 2019 (1,786 vs. 2,159, respectively, χ 2 goodness of fit test p < 0.0001) across 9 participating comprehensive stroke centers. Patients who did not receive any reperfusion therapy decreased by 16.6% in 2020 (1,527) compared to 2019 (1,832). Patients who received only intravenous thrombolytic (IVT) therapy decreased by 31.8% (107 vs. 157). Patients who received only mechanical thrombectomy (MT) increased by 3% (102 vs. 99). Patients who received both IVT and MT decreased by 31.8% (45 vs. 66). Recanalization treatment times in 2020 were comparable to 2019. CSCs serving a higher proportion of Latinx populations in the eastern parts of LAC experienced a higher incidence of MT in 2020 compared to 2019. Mild increase in stroke severity was seen in 2020 compared to 2019 (8.95 vs. 8.23, p = 0.046). A higher percentage of patients were discharged home in 2020 compared to 2019 (59.5 vs. 56.1%, p = 0.034), a lower percentage of patients were discharged to skilled nursing facility (16.1 vs. 20.7%, p = 0.0004), and a higher percentage of patients expired (8.6 vs. 6.3%, p = 0.008). Conclusion: LAC saw a decrease in overall stroke code activations in 2020 compared to 2019. Reperfusion treatment times remained comparable to prepandemic metrics. There has been an increase in severe stroke incidence and higher volume of thrombectomy treatments in Latinx communities within LAC during the pandemic of 2020. More patients were discharged home, less patients discharged to skilled nursing facilities, and more patients expired in 2020, compared to the same time frame in 2019. |
doi_str_mv | 10.1159/000516908 |
format | article |
fullrecord | <record><control><sourceid>gale_COVID</sourceid><recordid>TN_cdi_proquest_journals_2549158379</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A709901730</galeid><sourcerecordid>A709901730</sourcerecordid><originalsourceid>FETCH-LOGICAL-c550t-b783ec4feef22beda820bacce4ba62cf0bfee3756c5d13f9d5f1b21dfb7343a73</originalsourceid><addsrcrecordid>eNptkk1v1DAQhiMEoqVw4I6QpUoIDin-iNfxBWmVFlhppR4oXC3HGSdpkzjYSSX-PV62jXZR5YNHfp95bc9Mkrwl-IIQLj9jjDlZSZw_S05JRkkqRb56HmNMeIwFPklehXAbsRXJycvkhGVE8JyT06Qurn9tLlMi0aYftZmQG9DazBOgTTAN9K1BPybv7gDdeNBTD8OE9IQkKlw_emhgCO09PDJFlMEHpI13IaCtC2g91NBBeJ28sLoL8OZhP0t-fr26Kb6n2-tvm2K9TQ3neEpLkTMwmQWwlJZQ6ZziUhsDWalX1FhcRokJvjK8IszKiltSUlLZUrCMacHOki9733Eue6hMfJDXnRp922v_RzndqmNlaBtVu3uVMyZxRqPBxwcD737PECbVt8FA1-kB3BwU5RmXUlAqI3r-H3rrZj_E7-0oSXjOxAFV6w5UO1gX7zU7U7UWWEpMBMORuniCiqva9cANYNt4fpTw4SChAd1NTXDdPLVuCMfgpz34ryce7FIMgtVufNQyPpF9f1i9hXyclwi82wN32tfgF2DJP39SLq4u94QaK8v-AjaU0sc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2549158379</pqid></control><display><type>article</type><title>COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles</title><source>Coronavirus Research Database</source><creator>Padrick, M. Maximillian ; Sangha, Navdeep ; Paletz, Laurie ; Mirocha, James ; Figueroa, Sonia ; Manoukian, Vicki ; Schlick, Konrad ; Lyden, Patrick D. ; Liebeskind, David S. ; Chatfield, Fiona K. ; Tarpley, Jason W. ; Burgos, Adrian ; Tenser, Matthew ; Gaffney, Denise ; Pech, Marco A. ; Nazareth, Edward ; Jackson, Robert ; Kauffman, Helaine ; Arnold, Lisa ; Cox, Jennifer ; Joyce, Treasure ; Nakamura, Catrice ; Fitzgerald, Darcie ; Ogami, Kyle ; Steiner, Nili ; Wolber, Nicole ; Robertson, Betty ; Izzo, Rachel ; Gorski, Stefanie ; Manuel, Heather ; Valdez, Krystal ; Reyes, Liliana ; Sharma, Latisha K. ; Song, Shlee S.</creator><creatorcontrib>Padrick, M. Maximillian ; Sangha, Navdeep ; Paletz, Laurie ; Mirocha, James ; Figueroa, Sonia ; Manoukian, Vicki ; Schlick, Konrad ; Lyden, Patrick D. ; Liebeskind, David S. ; Chatfield, Fiona K. ; Tarpley, Jason W. ; Burgos, Adrian ; Tenser, Matthew ; Gaffney, Denise ; Pech, Marco A. ; Nazareth, Edward ; Jackson, Robert ; Kauffman, Helaine ; Arnold, Lisa ; Cox, Jennifer ; Joyce, Treasure ; Nakamura, Catrice ; Fitzgerald, Darcie ; Ogami, Kyle ; Steiner, Nili ; Wolber, Nicole ; Robertson, Betty ; Izzo, Rachel ; Gorski, Stefanie ; Manuel, Heather ; Valdez, Krystal ; Reyes, Liliana ; Sharma, Latisha K. ; Song, Shlee S.</creatorcontrib><description>Objective: To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Methods: Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. Results: There was a 17.3% decrease in stroke code activations across LAC in 2020 compared to 2019 (1,786 vs. 2,159, respectively, χ 2 goodness of fit test p < 0.0001) across 9 participating comprehensive stroke centers. Patients who did not receive any reperfusion therapy decreased by 16.6% in 2020 (1,527) compared to 2019 (1,832). Patients who received only intravenous thrombolytic (IVT) therapy decreased by 31.8% (107 vs. 157). Patients who received only mechanical thrombectomy (MT) increased by 3% (102 vs. 99). Patients who received both IVT and MT decreased by 31.8% (45 vs. 66). Recanalization treatment times in 2020 were comparable to 2019. CSCs serving a higher proportion of Latinx populations in the eastern parts of LAC experienced a higher incidence of MT in 2020 compared to 2019. Mild increase in stroke severity was seen in 2020 compared to 2019 (8.95 vs. 8.23, p = 0.046). A higher percentage of patients were discharged home in 2020 compared to 2019 (59.5 vs. 56.1%, p = 0.034), a lower percentage of patients were discharged to skilled nursing facility (16.1 vs. 20.7%, p = 0.0004), and a higher percentage of patients expired (8.6 vs. 6.3%, p = 0.008). Conclusion: LAC saw a decrease in overall stroke code activations in 2020 compared to 2019. Reperfusion treatment times remained comparable to prepandemic metrics. There has been an increase in severe stroke incidence and higher volume of thrombectomy treatments in Latinx communities within LAC during the pandemic of 2020. More patients were discharged home, less patients discharged to skilled nursing facilities, and more patients expired in 2020, compared to the same time frame in 2019.</description><identifier>ISSN: 1015-9770</identifier><identifier>EISSN: 1421-9786</identifier><identifier>DOI: 10.1159/000516908</identifier><identifier>PMID: 34175851</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Brain Ischemia - diagnosis ; Brain Ischemia - epidemiology ; Brain Ischemia - therapy ; Clinical Research in Stroke ; Comparative analysis ; COVID-19 ; Drug therapy ; Fibrinolytic Agents - adverse effects ; Humans ; Ischemia ; Ischemic Stroke ; Los Angeles - epidemiology ; Retrospective Studies ; SARS-CoV-2 ; Stroke (Disease) ; Stroke - diagnosis ; Stroke - epidemiology ; Stroke - therapy ; Thrombectomy ; Thrombolytic Therapy ; Time-to-Treatment ; Treatment Outcome</subject><ispartof>Cerebrovascular Diseases, 2021-12, Vol.50 (6), p.707-714</ispartof><rights>2021 S. Karger AG, Basel</rights><rights>2021 S. Karger AG, Basel.</rights><rights>COPYRIGHT 2021 S. Karger AG</rights><rights>2021. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.karger.com/Tap/Home/278492 Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.</rights><rights>Copyright © 2021 by S. Karger AG, Basel 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c550t-b783ec4feef22beda820bacce4ba62cf0bfee3756c5d13f9d5f1b21dfb7343a73</citedby><cites>FETCH-LOGICAL-c550t-b783ec4feef22beda820bacce4ba62cf0bfee3756c5d13f9d5f1b21dfb7343a73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2549158379?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>780,784,885,27924,38515,43894</link.rule.ids><linktorsrc>$$Uhttps://www.proquest.com/docview/2549158379?pq-origsite=primo$$EView_record_in_ProQuest$$FView_record_in_$$GProQuest</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34175851$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Padrick, M. Maximillian</creatorcontrib><creatorcontrib>Sangha, Navdeep</creatorcontrib><creatorcontrib>Paletz, Laurie</creatorcontrib><creatorcontrib>Mirocha, James</creatorcontrib><creatorcontrib>Figueroa, Sonia</creatorcontrib><creatorcontrib>Manoukian, Vicki</creatorcontrib><creatorcontrib>Schlick, Konrad</creatorcontrib><creatorcontrib>Lyden, Patrick D.</creatorcontrib><creatorcontrib>Liebeskind, David S.</creatorcontrib><creatorcontrib>Chatfield, Fiona K.</creatorcontrib><creatorcontrib>Tarpley, Jason W.</creatorcontrib><creatorcontrib>Burgos, Adrian</creatorcontrib><creatorcontrib>Tenser, Matthew</creatorcontrib><creatorcontrib>Gaffney, Denise</creatorcontrib><creatorcontrib>Pech, Marco A.</creatorcontrib><creatorcontrib>Nazareth, Edward</creatorcontrib><creatorcontrib>Jackson, Robert</creatorcontrib><creatorcontrib>Kauffman, Helaine</creatorcontrib><creatorcontrib>Arnold, Lisa</creatorcontrib><creatorcontrib>Cox, Jennifer</creatorcontrib><creatorcontrib>Joyce, Treasure</creatorcontrib><creatorcontrib>Nakamura, Catrice</creatorcontrib><creatorcontrib>Fitzgerald, Darcie</creatorcontrib><creatorcontrib>Ogami, Kyle</creatorcontrib><creatorcontrib>Steiner, Nili</creatorcontrib><creatorcontrib>Wolber, Nicole</creatorcontrib><creatorcontrib>Robertson, Betty</creatorcontrib><creatorcontrib>Izzo, Rachel</creatorcontrib><creatorcontrib>Gorski, Stefanie</creatorcontrib><creatorcontrib>Manuel, Heather</creatorcontrib><creatorcontrib>Valdez, Krystal</creatorcontrib><creatorcontrib>Reyes, Liliana</creatorcontrib><creatorcontrib>Sharma, Latisha K.</creatorcontrib><creatorcontrib>Song, Shlee S.</creatorcontrib><title>COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles</title><title>Cerebrovascular Diseases</title><addtitle>Cerebrovasc Dis</addtitle><description>Objective: To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Methods: Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. Results: There was a 17.3% decrease in stroke code activations across LAC in 2020 compared to 2019 (1,786 vs. 2,159, respectively, χ 2 goodness of fit test p < 0.0001) across 9 participating comprehensive stroke centers. Patients who did not receive any reperfusion therapy decreased by 16.6% in 2020 (1,527) compared to 2019 (1,832). Patients who received only intravenous thrombolytic (IVT) therapy decreased by 31.8% (107 vs. 157). Patients who received only mechanical thrombectomy (MT) increased by 3% (102 vs. 99). Patients who received both IVT and MT decreased by 31.8% (45 vs. 66). Recanalization treatment times in 2020 were comparable to 2019. CSCs serving a higher proportion of Latinx populations in the eastern parts of LAC experienced a higher incidence of MT in 2020 compared to 2019. Mild increase in stroke severity was seen in 2020 compared to 2019 (8.95 vs. 8.23, p = 0.046). A higher percentage of patients were discharged home in 2020 compared to 2019 (59.5 vs. 56.1%, p = 0.034), a lower percentage of patients were discharged to skilled nursing facility (16.1 vs. 20.7%, p = 0.0004), and a higher percentage of patients expired (8.6 vs. 6.3%, p = 0.008). Conclusion: LAC saw a decrease in overall stroke code activations in 2020 compared to 2019. Reperfusion treatment times remained comparable to prepandemic metrics. There has been an increase in severe stroke incidence and higher volume of thrombectomy treatments in Latinx communities within LAC during the pandemic of 2020. More patients were discharged home, less patients discharged to skilled nursing facilities, and more patients expired in 2020, compared to the same time frame in 2019.</description><subject>Brain Ischemia - diagnosis</subject><subject>Brain Ischemia - epidemiology</subject><subject>Brain Ischemia - therapy</subject><subject>Clinical Research in Stroke</subject><subject>Comparative analysis</subject><subject>COVID-19</subject><subject>Drug therapy</subject><subject>Fibrinolytic Agents - adverse effects</subject><subject>Humans</subject><subject>Ischemia</subject><subject>Ischemic Stroke</subject><subject>Los Angeles - epidemiology</subject><subject>Retrospective Studies</subject><subject>SARS-CoV-2</subject><subject>Stroke (Disease)</subject><subject>Stroke - diagnosis</subject><subject>Stroke - epidemiology</subject><subject>Stroke - therapy</subject><subject>Thrombectomy</subject><subject>Thrombolytic Therapy</subject><subject>Time-to-Treatment</subject><subject>Treatment Outcome</subject><issn>1015-9770</issn><issn>1421-9786</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><recordid>eNptkk1v1DAQhiMEoqVw4I6QpUoIDin-iNfxBWmVFlhppR4oXC3HGSdpkzjYSSX-PV62jXZR5YNHfp95bc9Mkrwl-IIQLj9jjDlZSZw_S05JRkkqRb56HmNMeIwFPklehXAbsRXJycvkhGVE8JyT06Qurn9tLlMi0aYftZmQG9DazBOgTTAN9K1BPybv7gDdeNBTD8OE9IQkKlw_emhgCO09PDJFlMEHpI13IaCtC2g91NBBeJ28sLoL8OZhP0t-fr26Kb6n2-tvm2K9TQ3neEpLkTMwmQWwlJZQ6ZziUhsDWalX1FhcRokJvjK8IszKiltSUlLZUrCMacHOki9733Eue6hMfJDXnRp922v_RzndqmNlaBtVu3uVMyZxRqPBxwcD737PECbVt8FA1-kB3BwU5RmXUlAqI3r-H3rrZj_E7-0oSXjOxAFV6w5UO1gX7zU7U7UWWEpMBMORuniCiqva9cANYNt4fpTw4SChAd1NTXDdPLVuCMfgpz34ryce7FIMgtVufNQyPpF9f1i9hXyclwi82wN32tfgF2DJP39SLq4u94QaK8v-AjaU0sc</recordid><startdate>20211201</startdate><enddate>20211201</enddate><creator>Padrick, M. Maximillian</creator><creator>Sangha, Navdeep</creator><creator>Paletz, Laurie</creator><creator>Mirocha, James</creator><creator>Figueroa, Sonia</creator><creator>Manoukian, Vicki</creator><creator>Schlick, Konrad</creator><creator>Lyden, Patrick D.</creator><creator>Liebeskind, David S.</creator><creator>Chatfield, Fiona K.</creator><creator>Tarpley, Jason W.</creator><creator>Burgos, Adrian</creator><creator>Tenser, Matthew</creator><creator>Gaffney, Denise</creator><creator>Pech, Marco A.</creator><creator>Nazareth, Edward</creator><creator>Jackson, Robert</creator><creator>Kauffman, Helaine</creator><creator>Arnold, Lisa</creator><creator>Cox, Jennifer</creator><creator>Joyce, Treasure</creator><creator>Nakamura, Catrice</creator><creator>Fitzgerald, Darcie</creator><creator>Ogami, Kyle</creator><creator>Steiner, Nili</creator><creator>Wolber, Nicole</creator><creator>Robertson, Betty</creator><creator>Izzo, Rachel</creator><creator>Gorski, Stefanie</creator><creator>Manuel, Heather</creator><creator>Valdez, Krystal</creator><creator>Reyes, Liliana</creator><creator>Sharma, Latisha K.</creator><creator>Song, Shlee S.</creator><general>S. Karger AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>COVID</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20211201</creationdate><title>COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles</title><author>Padrick, M. Maximillian ; Sangha, Navdeep ; Paletz, Laurie ; Mirocha, James ; Figueroa, Sonia ; Manoukian, Vicki ; Schlick, Konrad ; Lyden, Patrick D. ; Liebeskind, David S. ; Chatfield, Fiona K. ; Tarpley, Jason W. ; Burgos, Adrian ; Tenser, Matthew ; Gaffney, Denise ; Pech, Marco A. ; Nazareth, Edward ; Jackson, Robert ; Kauffman, Helaine ; Arnold, Lisa ; Cox, Jennifer ; Joyce, Treasure ; Nakamura, Catrice ; Fitzgerald, Darcie ; Ogami, Kyle ; Steiner, Nili ; Wolber, Nicole ; Robertson, Betty ; Izzo, Rachel ; Gorski, Stefanie ; Manuel, Heather ; Valdez, Krystal ; Reyes, Liliana ; Sharma, Latisha K. ; Song, Shlee S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c550t-b783ec4feef22beda820bacce4ba62cf0bfee3756c5d13f9d5f1b21dfb7343a73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Brain Ischemia - diagnosis</topic><topic>Brain Ischemia - epidemiology</topic><topic>Brain Ischemia - therapy</topic><topic>Clinical Research in Stroke</topic><topic>Comparative analysis</topic><topic>COVID-19</topic><topic>Drug therapy</topic><topic>Fibrinolytic Agents - adverse effects</topic><topic>Humans</topic><topic>Ischemia</topic><topic>Ischemic Stroke</topic><topic>Los Angeles - epidemiology</topic><topic>Retrospective Studies</topic><topic>SARS-CoV-2</topic><topic>Stroke (Disease)</topic><topic>Stroke - diagnosis</topic><topic>Stroke - epidemiology</topic><topic>Stroke - therapy</topic><topic>Thrombectomy</topic><topic>Thrombolytic Therapy</topic><topic>Time-to-Treatment</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Padrick, M. Maximillian</creatorcontrib><creatorcontrib>Sangha, Navdeep</creatorcontrib><creatorcontrib>Paletz, Laurie</creatorcontrib><creatorcontrib>Mirocha, James</creatorcontrib><creatorcontrib>Figueroa, Sonia</creatorcontrib><creatorcontrib>Manoukian, Vicki</creatorcontrib><creatorcontrib>Schlick, Konrad</creatorcontrib><creatorcontrib>Lyden, Patrick D.</creatorcontrib><creatorcontrib>Liebeskind, David S.</creatorcontrib><creatorcontrib>Chatfield, Fiona K.</creatorcontrib><creatorcontrib>Tarpley, Jason W.</creatorcontrib><creatorcontrib>Burgos, Adrian</creatorcontrib><creatorcontrib>Tenser, Matthew</creatorcontrib><creatorcontrib>Gaffney, Denise</creatorcontrib><creatorcontrib>Pech, Marco A.</creatorcontrib><creatorcontrib>Nazareth, Edward</creatorcontrib><creatorcontrib>Jackson, Robert</creatorcontrib><creatorcontrib>Kauffman, Helaine</creatorcontrib><creatorcontrib>Arnold, Lisa</creatorcontrib><creatorcontrib>Cox, Jennifer</creatorcontrib><creatorcontrib>Joyce, Treasure</creatorcontrib><creatorcontrib>Nakamura, Catrice</creatorcontrib><creatorcontrib>Fitzgerald, Darcie</creatorcontrib><creatorcontrib>Ogami, Kyle</creatorcontrib><creatorcontrib>Steiner, Nili</creatorcontrib><creatorcontrib>Wolber, Nicole</creatorcontrib><creatorcontrib>Robertson, Betty</creatorcontrib><creatorcontrib>Izzo, Rachel</creatorcontrib><creatorcontrib>Gorski, Stefanie</creatorcontrib><creatorcontrib>Manuel, Heather</creatorcontrib><creatorcontrib>Valdez, Krystal</creatorcontrib><creatorcontrib>Reyes, Liliana</creatorcontrib><creatorcontrib>Sharma, Latisha K.</creatorcontrib><creatorcontrib>Song, Shlee S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Coronavirus Research Database</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cerebrovascular Diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Padrick, M. Maximillian</au><au>Sangha, Navdeep</au><au>Paletz, Laurie</au><au>Mirocha, James</au><au>Figueroa, Sonia</au><au>Manoukian, Vicki</au><au>Schlick, Konrad</au><au>Lyden, Patrick D.</au><au>Liebeskind, David S.</au><au>Chatfield, Fiona K.</au><au>Tarpley, Jason W.</au><au>Burgos, Adrian</au><au>Tenser, Matthew</au><au>Gaffney, Denise</au><au>Pech, Marco A.</au><au>Nazareth, Edward</au><au>Jackson, Robert</au><au>Kauffman, Helaine</au><au>Arnold, Lisa</au><au>Cox, Jennifer</au><au>Joyce, Treasure</au><au>Nakamura, Catrice</au><au>Fitzgerald, Darcie</au><au>Ogami, Kyle</au><au>Steiner, Nili</au><au>Wolber, Nicole</au><au>Robertson, Betty</au><au>Izzo, Rachel</au><au>Gorski, Stefanie</au><au>Manuel, Heather</au><au>Valdez, Krystal</au><au>Reyes, Liliana</au><au>Sharma, Latisha K.</au><au>Song, Shlee S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles</atitle><jtitle>Cerebrovascular Diseases</jtitle><addtitle>Cerebrovasc Dis</addtitle><date>2021-12-01</date><risdate>2021</risdate><volume>50</volume><issue>6</issue><spage>707</spage><epage>714</epage><pages>707-714</pages><issn>1015-9770</issn><eissn>1421-9786</eissn><abstract>Objective: To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Methods: Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. Results: There was a 17.3% decrease in stroke code activations across LAC in 2020 compared to 2019 (1,786 vs. 2,159, respectively, χ 2 goodness of fit test p < 0.0001) across 9 participating comprehensive stroke centers. Patients who did not receive any reperfusion therapy decreased by 16.6% in 2020 (1,527) compared to 2019 (1,832). Patients who received only intravenous thrombolytic (IVT) therapy decreased by 31.8% (107 vs. 157). Patients who received only mechanical thrombectomy (MT) increased by 3% (102 vs. 99). Patients who received both IVT and MT decreased by 31.8% (45 vs. 66). Recanalization treatment times in 2020 were comparable to 2019. CSCs serving a higher proportion of Latinx populations in the eastern parts of LAC experienced a higher incidence of MT in 2020 compared to 2019. Mild increase in stroke severity was seen in 2020 compared to 2019 (8.95 vs. 8.23, p = 0.046). A higher percentage of patients were discharged home in 2020 compared to 2019 (59.5 vs. 56.1%, p = 0.034), a lower percentage of patients were discharged to skilled nursing facility (16.1 vs. 20.7%, p = 0.0004), and a higher percentage of patients expired (8.6 vs. 6.3%, p = 0.008). Conclusion: LAC saw a decrease in overall stroke code activations in 2020 compared to 2019. Reperfusion treatment times remained comparable to prepandemic metrics. There has been an increase in severe stroke incidence and higher volume of thrombectomy treatments in Latinx communities within LAC during the pandemic of 2020. More patients were discharged home, less patients discharged to skilled nursing facilities, and more patients expired in 2020, compared to the same time frame in 2019.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>34175851</pmid><doi>10.1159/000516908</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | ISSN: 1015-9770 |
ispartof | Cerebrovascular Diseases, 2021-12, Vol.50 (6), p.707-714 |
issn | 1015-9770 1421-9786 |
language | eng |
recordid | cdi_proquest_journals_2549158379 |
source | Coronavirus Research Database |
subjects | Brain Ischemia - diagnosis Brain Ischemia - epidemiology Brain Ischemia - therapy Clinical Research in Stroke Comparative analysis COVID-19 Drug therapy Fibrinolytic Agents - adverse effects Humans Ischemia Ischemic Stroke Los Angeles - epidemiology Retrospective Studies SARS-CoV-2 Stroke (Disease) Stroke - diagnosis Stroke - epidemiology Stroke - therapy Thrombectomy Thrombolytic Therapy Time-to-Treatment Treatment Outcome |
title | COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T10%3A23%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_COVID&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=COVID-19%20Impact%20on%20Acute%20Ischemic%20Stroke%20Treatment%20at%209%20Comprehensive%20Stroke%20Centers%20across%20Los%20Angeles&rft.jtitle=Cerebrovascular%20Diseases&rft.au=Padrick,%20M.%20Maximillian&rft.date=2021-12-01&rft.volume=50&rft.issue=6&rft.spage=707&rft.epage=714&rft.pages=707-714&rft.issn=1015-9770&rft.eissn=1421-9786&rft_id=info:doi/10.1159/000516908&rft_dat=%3Cgale_COVID%3EA709901730%3C/gale_COVID%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c550t-b783ec4feef22beda820bacce4ba62cf0bfee3756c5d13f9d5f1b21dfb7343a73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2549158379&rft_id=info:pmid/34175851&rft_galeid=A709901730&rfr_iscdi=true |